PHERD-02

N/A

Report date: 2023/05/17 15:04:20
NME

Base Information

Drug NamePHERD-02
Drug Alias NamePHERD-02
ClassificationSmall molecules
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 degraders
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZenopharm
China Registration ClassN/A

Develop Information

Active CompaniesZenopharm
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A